News and Trends 12 Dec 2022
OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data
OSE Immunotherapeutics SA has presented the latest preclinical data on the use of its anti-IL-7 receptor (IL-7R) antagonist OSE-127 for…
OSE Immunotherapeutics
- Latest Posts
News and Trends 23 Nov 2022
Significant therapeutic potential of OSE Immunotherapeutics’ CLEC-1 published
OSE Immunotherapeutics SA has announced the publication of data in the peer-reviewed journal Science Advances on a first-in-class preclinical program…
News and Trends 3 Nov 2022
Servier and OSE Immunotherapeutics complete enrollment in Sjögren’s syndrome trial
Servier and French biotech company OSE Immunotherapeutics SA have completed patient enrollment in a phase 2a clinical trial evaluating the…
In Depth 6 Jul 2020
How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for developing new treatments for infectious…
ADVERTISEMENT
News and Trends 13 Feb 2020
French Partnership Deploys AI for Antibody Drug Discovery
French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence.…
Best in Biotech 21 May 2019
The Top 20 Women in Leading Biotech Roles in Europe
The biotech industry has often been criticized for its lack of gender diversity. While there is still a long way…
News and Trends 27 Mar 2019
Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy
The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop treatments for tumors that don’t…
News and Trends 5 Apr 2018
Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech
OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has set its eyes on a…
Best in Biotech 8 Mar 2018
Say Hello to the Top 14 Entrepreneurial Women in European Biotech
Today, March 8, is international women's day. To celebrate the achievements of women we're revisiting our list of the women…
News and Trends 22 Jun 2017
Immunotherapy for Bowel Disease Gets €2.6M Milestone Payment from Bpifrance
OSE Immunotherapeutics has successfully completed the necessary milestones to bring a treatment for autoimmune disease to the clinic, triggering a…
ADVERTISEMENT
News and Trends 24 May 2017
French Biotech Enters New Agreement to Advance its IBD Immunotherapy
OSE Immunotherapeutics has teamed up with Selexis in a new license agreement to support the development of its IL-7 antagonist…
News and Trends 7 Nov 2016
Catching Up with the French Leader in Immuno-Oncology #BIOEurope
Despite the deflating attitudes towards immuno-oncology, OSE Immunotherapeutics is forging ahead. We caught up with the CEO, Dominique Costantini, at…
News and Trends 25 Mar 2016
Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris
This week, we head up full speed from Geneva with our eyes aiming towards Paris. Known for its beauty, bohemian lifestyle…
News and Trends 8 Feb 2016
French Biotech Launches Phase III Global Trial for Lung Cancer Drug
OSE Pharma (France) has initiated the US phase III trial, Atalante 1. This global, pivotal trial will evaluate Tedopi, the company’s lead…
News and Trends 7 Jan 2016
3 French Bioentrepreneurs are Awarded for Being Stubborn
Building a company is extremely difficult and obstination is sometimes needed to reach success. The organisation, France Biotech, has given…
News and Trends 5 Jan 2016
How these Latest Trials Prove PD-L1 as The Breakthrough Trend in Immuno-Oncology that is Here to Stay…
By targeting platinum resistant Ovarian cancer, Avelumab is a new anti-PD-L1 checkpoint inhibitor on the Cancer block. This just affirms…
ADVERTISEMENT
News and Trends 17 Sep 2015
France’s leading Female Bio-entrepreneur joins board of Abivax
Dominique Costantini is one of France's leading biotech figures, with over 20 years experience on boards, partnerships and business backing…
News and Trends 9 Sep 2015
Encouraging results from Tedopi Phase II trials in patients with brain metastases
French Immuno-oncology Biotech OSE Pharma has announced its phase II results for Tedopi trials showing outcome for patients with brain…
News and Trends 19 Aug 2015
Paris is Europe’s biggest Biocluster, but nobody knows it …
Paris is well-known for being the most beautiful city in the world. But did you also know that it concentrates…
News and Trends 27 Mar 2015
OSE Pharma raised €21.1 Million
OSE Pharma’s Initial Public Offering couldn’t have been more successful as it just raised €21.1M. Noticing the strong demand for…
